Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual MeetingBusiness
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual MeetingBusiness
Colorado Substance Abuse Treatment Clinic and Owner Agree to Settle False Claims Act AllegationsUncategorized
Treatment Developed by CHOP Researchers Prevents Hypoglycemia in Children with HyperinsulinismBusiness
John Theurer Cancer Center Treats First Patient in U.S. with Investigational New Treatment for Brain CancerBusiness
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with UveitisBusiness
Clearbrook Treatment Centers And Andrew Brown’s Drug Store Agree To Pay The United States Civil Penalties For Violations Of The Controlled Substances ActUncategorized
Federal Court Rules in Favor of the Justice Department in Lawsuit Against City of Troy, Michigan For Restrictions on Places of Worship and Treatment of Muslim Religious GroupUncategorized
Recovery Centers of America at St. Charles Designated as a Blue Distinction® Center for Substance Use Treatment and RecoveryBusiness
United States Files Enforcement Action to Stop Deceptive Marketing of Herbal Tea Product Advertised as Covid-19 TreatmentUncategorized
New Jersey gunmaker donates $32,000 in rifles to help pay for 4-year-old girl’s cancer treatmentBusiness
Former Project Manager of the El Reno Wastewater Treatment Plant Sentenced After Pleading Guilty to Violating The Clean Water ActUncategorized
